Doylestown, PA, United States of America

Thomas Hofmann

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Seattle, WA (US) (2008)
  • Doylestown, PA (US) (2011 - 2023)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Thomas Hofmann

Introduction

Thomas Hofmann is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for inhalation therapies. With a total of 9 patents to his name, Hofmann's work has the potential to impact the treatment of various pulmonary infections.

Latest Patents

Hofmann's latest patents focus on compositions of clofazimine, which include combinations and processes for their preparation. These pharmaceutical compositions are designed for inhalation and contain a therapeutically effective dose of clofazimine in the form of a suspension. Additionally, his inventions provide pharmaceutical combinations comprising clofazimine in aerosol form for pulmonary inhalation. These innovations may be utilized in the treatment and prophylaxis of pulmonary infections caused by mycobacteria, other gram-positive bacteria, and pulmonary fungal infections.

Career Highlights

Throughout his career, Hofmann has worked with prominent companies in the pharmaceutical industry, including Gilead Sciences, Inc. and Activaero GmbH Research & Development. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Hofmann has collaborated with notable professionals in his field, including Alan Bruce Montgomery and Kevin Stapleton. These partnerships have likely enhanced his research and development efforts.

Conclusion

Thomas Hofmann's contributions to pharmaceutical innovations, particularly in inhalation therapies, demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment options for patients with pulmonary infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…